ATR earnings

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following first quarter results for the period ended March 31, 2026, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430601030/en/Aptar Reports First Quarter 2026 Results First Quarter 2026 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 11% and core sales were flat Reported net income decreased 8% t

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, including dosing and protection technologies, and consumer product dispensing, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is May 27, 2026, to stockholders of record as of May 6, 2026. As previously announced, Aptar will hold a conference call on Friday, May 1, 2026, at 8:00 a.m. Central Time to discuss the Company's first quarter results for 2026. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. A replay of the conference call can also be accessed for a limited time o

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following fourth quarter results for the period ended December 31, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205227722/en/Photo: Aptar Fourth Quarter 2025 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 14% and core sales increased 5%—all three segments delivered core sales growth Reporte

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is February 25, 2026, to stockholders of record as of February 4, 2026. As previously announced, Aptar will hold a conference call on Friday, February 6, 2026, at 8:00 a.m. Central Time to discuss the Company's fourth quarter and year-end results for 2025. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. A replay of the conference call can also be accessed fo

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases. Quarterly Conference Calls   Press Release(1) Conference Call(2) 4th Quarter and Annual 2025 Results February 5, 2026 February 6, 2026, at 8:00 a.m. CT 1st Quarter 2026 Results April 30, 2026 May 1, 2026, at 8:00 a.m. CT 2nd Quarter 2026 Results July 30, 2026 July 31, 2026, at 8:00 a.m. CT 3rd Quarter 2026 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, today reported the following third quarter results for the period ended September 30, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030956269/en/Aptar Reports Third Quarter 2025 Results Third Quarter 2025 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 6% and core sales increased 1% Strong product volume growth

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following second quarter results for the period ended June 30, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250731446602/en/Aptar Reports Second Quarter 2025 Results Second Quarter 2025 Highlights (compared to the prior year quarter) Reported sales increased 6% and core sales increased 3% Reported net income increased 24% to $112 million and adjusted EBITDA increased 13% from the prior year to $218 million Rep

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is August 14, 2025 to stockholders of record as of July 24, 2025. As previously announced, Aptar will hold a conference call on Friday, August 1, 2025 at 8:00 a.m. Central Time to discuss the Company's second quarter results for 2025. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investors page of the website. A

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following first quarter results for the period ended March 31, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501642213/en/Aptar Reports First Quarter 2025 Results First Quarter 2025 Highlights (compared to the prior year quarter) Reported sales of $887 million, a 3% decrease, and reported net income of $79 million, a 5% decrease Core sales were flat and adjusted EBITDA increased 3% from the prior year to $183 mill

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is May 22, 2025, to stockholders of record as of May 1, 2025. As previously announced, Aptar will hold a conference call on Friday, May 2, 2025 at 8:00 a.m. Central Time to discuss the Company's first quarter results for 2025. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investors page of the website. About Aptar

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong fourth quarter results due to solid operational performance driven by top and bottom line improvements. Results were driven by sales growth in pharma solutions, increased demand for closures technologies and productivity gains across the company. Reported sales increased by 1% and core sales increased by 2% due to a negative currency effect. Aptar reported net income of $101 million for the quarter, a 62% increase from the prior year. In addition, the quarterly results benefited from a lower effective tax rate. This press release features multimedi

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.45 per share. The payment date is February 26, 2025, to stockholders of record as of February 5, 2025. As previously announced, Aptar will hold a conference call on Friday, February 7, 2025 at 8:00 a.m. Central Time to discuss the Company's fourth quarter and year-end results for 2024. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases. Quarterly Conference Calls   Press Release (1) Conference Call (2) 4th Quarter and Annual 2024 Results February 6, 2025 February 7, 2025, at 8:00 a.m. CT 1st Quarter 2025 Results May 1, 2025 May 2, 2025, at 8:00 a.m. CT 2nd Quarter 2025 Results July 31, 2025 August 1, 2025, at 8:00 a.m. CT 3rd Quarter 2025

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong third quarter results due to solid operational performance and margin improvement across the company. Results were driven by growth in proprietary drug delivery systems, as well as increased demand for closure technologies. Reported sales and core sales increased by 2%, as currency and acquisition effects did not impact the quarter. Aptar reported net income of $100 million for the quarter, a 19% increase from the prior year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241024363414/en/

The Board of Directors of AptarGroup, Inc. (NYSE:ATR) authorized the repurchase of up to $500 million of the Company's common stock. This new authorization replaces all previous authorizations. Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions. The Board also declared a quarterly cash dividend of $0.45 per share. The payment date is November 14, 2024, to stockholders of record as of October 24, 2024. Stephan Tanda, President and CEO, commented, "Aptar maintains a balanced approach to capital allocation, focused on returning capital to shareholders, as well as reinvesting in the business through capacity ex

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported solid second quarter results driven by continued growth of the company's proprietary drug delivery systems and margin improvement. Reported sales increased by 2% and core sales, excluding currency and acquisition effects, increased by 3%. Aptar reported net income of $90 million for the quarter, a 9% increase from the prior year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725389689/en/Photo: Aptar "Strong sales growth in our Pharma business and broad-based margin expansion helped us achi

Following an increase of almost 8% a year ago AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share, an almost 10% increase from the previous dividend amount, bringing the new annualized dividend to $1.80 per share. The payment date is August 15, 2024, to stockholders of record as of July 25, 2024. Stephan B. Tanda, Aptar President and CEO, commented, "In light of our continued strong performance across all of our key financial metrics, as well as future growth opportunities, the Board of Directors approved an increase in the quarterly dividend. Over the

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong first quarter results driven by continued growth of the company's proprietary drug delivery systems, increased injectables sales and an improving picture for consumer dispensing technologies in North America. Reported sales increased by 6% and core sales, excluding currency and acquisition effects, increased by 5%. Aptar reported net income of $83 million for the quarter, a 52% increase over the prior year. Reported earnings per share increased 50% to $1.23 and adjusted earnings per share increased 31% to $1.26. This press release features multimed

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.41 per share. The payment date is May 16, 2024, to stockholders of record as of April 25, 2024. As previously announced, Aptar will hold a conference call on Friday, April 26, 2024 at 8:00 a.m. Central Time to discuss the Company's first quarter results for 2024. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investors page of the website. Abo

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong fourth quarter operational results driven by double-digit growth of the company's proprietary drug delivery systems and strong growth for fragrance dispensing technologies. Reported sales increased by 5% and core sales, excluding currency and acquisition effects, increased by 2%. Aptar reported net income of $62 million for the quarter, a 6% increase over the prior year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240208100452/en/Photo: Aptar "I am pleased to report that we delivered

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.41 per share. The payment date is February 22, 2024, to stockholders of record as of February 1, 2024. As previously announced, Aptar will hold a conference call on Friday, February 9, 2024 at 8:00 a.m. Central Time to discuss the Company's fourth quarter and year-end results for 2023. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investors pag

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases. Quarterly Conference Calls   Press Release (1) Conference Call (2) 4th Quarter and Annual 2023 Results February 8, 2024 February 9, 2024, at 8:00 a.m. CT 1st Quarter 2024 Results April 25, 2024 April 26, 2024, at 8:00 a.m. CT 2nd Quarter 2024 Results July 25, 2024 July 26, 2024, at 8:00 a.m. CT 3rd Quarter 2024 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong operational performance driven by continued growth of the company's proprietary drug delivery systems. Strong sales from prestige and mass fragrance dispensing devices also contributed positively to the results. Reported sales increased by 7% and core sales, excluding currency and acquisition effects, increased by 2%. Aptar reported net income of $84 million for the quarter, a 55% increase over the prior year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231025463223/en/Photo: Aptar Co

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.41 per share. The payment date is November 16, 2023, to stockholders of record as of October 26, 2023. As previously announced, Aptar will hold a conference call on Thursday, October 26, 2023 at 8:00 a.m. Central Time to discuss the Company's third quarter results for 2023. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investors page of the web

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong operational performance driven by continued growth of the company's proprietary drug delivery systems and significant sequential improvement in injectables sales as Enterprise Resource Planning (ERP) system implementation effects moderated. Strong sales from prestige and mass fragrance also contributed positively to the results. Reported sales increased by 6% and core sales, excluding currency and acquisition effects, increased by 4%. Aptar reported net income of $83 million for the quarter, a 31% increase over the prior year. This press release fe

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.41 per share, an almost 8% increase from the previous dividend amount, bringing the new annualized dividend to $1.64 per share. The payment date is August 17, 2023, to stockholders of record as of July 27, 2023. Stephan Tanda, Aptar President and CEO, commented, "In light of our growth momentum, accelerating performance and strong financial position, the Board of Directors approved an increase in the quarterly dividend. In 2022, we returned more than $190 million to our stockholders through dividends a

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported strong operational performance driven by Aptar's Pharma and Beauty segments. Reported sales increased by 2% and core sales, excluding currency and acquisition effects, increased 4%. Aptar reported net income of $55 million for the quarter, a 12% decrease over the prior year, primarily due to restructuring charges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230427005940/en/Photo: Aptar "We are pleased to report a very positive start to 2023, driven by core sales growth i

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is May 25, 2023, to stockholders of record as of May 4, 2023. As previously announced, Aptar will hold a conference call on Friday, April 28, 2023 at 8:00 a.m. Central Time to discuss the Company's first quarter results for 2023. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investors page of

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported net income of $59 million for the quarter ended December 31, 2022, a 2% increase over the prior year. Reported sales decreased 2% and core sales, excluding currency and acquisition effects, increased by 4% over the prior year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230216005741/en/Photo: Aptar Commenting on the fourth quarter and full year results, Stephan B. Tanda, Aptar President and CEO, said, "We finished the year with a solid quarter due to strong volume growth

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is February 23, 2023, to stockholders of record as of February 2, 2023. As previously announced, Aptar will hold a conference call on Friday, February 17, 2023 at 8:00 a.m. Central Time to discuss the Company's fourth quarter and year-end results for 2022. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases. Quarterly Conference Calls   Press Release (1) Conference Call (2) 4th Quarter and Annual 2022 Results February 16, 2023 February 17, 2023, at 8:00 a.m. CT   1st Quarter 2023 Results April 27, 2023 April 28, 2023, at 8:00 a.m. CT   2nd Quarter 2023 Results July 27, 2023 July 28, 2023, at 8:00 a.m. CT   3rd Quarter

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported net income of $54 million for the quarter ended September 30, 2022, a 15% increase over the prior year. Reported sales grew 1% and core sales, excluding currency and acquisition effects, increased by 9% over the prior year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221027006100/en/Photo: Aptar "Aptar performed well during the third quarter, delivering solid results while continuing to adapt to a challenging and uncertain economic backdrop. Our Pharma segment saw double-

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is November 16, 2022, to stockholders of record as of October 26, 2022. As previously announced, Aptar will hold a conference call on Friday, October 28, 2022 at 8:00 a.m. Central Time to discuss the Company's third quarter results for 2022. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investo

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported net income of $64 million for the quarter ended June 30, 2022, a 15% increase over the prior year. Reported sales grew 4% and core sales increased by 10% over the prior year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220728005988/en/Photo: Aptar "Aptar delivered a strong quarter, remaining resilient while navigating a very dynamic and uncertain environment. As we look to the year ahead, we will remain focused on pricing initiatives to help offset continued rising input

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is August 17, 2022, to stockholders of record as of July 27, 2022. As previously announced, Aptar will hold a conference call on Friday, July 29, 2022 at 8:00 a.m. Central Time to discuss the Company's second quarter results for 2022. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investors page

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported first quarter results for 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220428006249/en/Photo: Aptar First Quarter 2022 Summary Reported sales grew 9% and core sales (excluding currency effects and acquisitions) grew 13% with double-digit core growth in each segment Pharma segment posted sales growth in all markets including the prescription drug division as demand for allergic rhinitis and asthma devices began to recover Reported earnings per share of $0.93 com

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is May 18, 2022, to stockholders of record as of April 27, 2022. As previously announced, Aptar will hold a conference call on Friday, April 29, 2022 at 8:00 a.m. Central Time to discuss the Company's first quarter results for 2022. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investors page o

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported fourth quarter and annual results for 2021. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220217005920/en/Photo: Aptar Fourth Quarter 2021 Summary Strong top line growth across each segment resulted in reported sales up 9% and core sales (excluding currency effects and acquisitions) up 10% Reported earnings per share increased 8% to $0.85 Adjusted earnings per share (excluding restructuring charges, the unrealized loss on the equity investment and acquisition costs) i

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today declared a quarterly cash dividend of $0.38 per share. The payment date is February 23, 2022, to stockholders of record as of February 3, 2022. As previously announced, Aptar will hold a conference call on Friday, February 18, 2022 at 8:00 a.m. Central Time to discuss the Company's fourth quarter and year-end results for 2021. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Inves

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases. Quarterly Conference Calls   Press Release (1) Conference Call (2) 4th Quarter and Annual 2021 Results February 17, 2022 February 18, 2022, at 8:00 a.m. CT 1st Quarter 2022 Results April 28, 2022 April 29, 2022, at 8:00 a.m. CT 2nd Quarter 2022 Results July 28, 2022 July 29, 2022, at 8:00 a.m. CT 3rd Quarter 2022 Results October 27, 2022

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today reported third quarter results for 2021. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211028006238/en/Photo: Aptar Third Quarter 2021 Summary Reported sales grew 9%, primarily driven by double-digit core sales growth in Beauty + Home and Food + Beverage from a combination of price increases and volume growth Core sales (excluding currency effects) increased 8% Pharma sales declined slightly compared to the prior year Reported earnings per share totaled $0.70 and included restructuring

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today declared a quarterly cash dividend of $0.38 per share. The payment date is November 17, 2021, to stockholders of record as of October 27, 2021. As previously announced, Aptar will hold a conference call on Friday, October 29, 2021 at 8:00 a.m. Central Time to discuss the Company's third quarter results for 2021. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investors page of th

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today declared a quarterly cash dividend of $0.38 per share. The payment date is August 25, 2021, to stockholders of record as of August 4, 2021. As previously announced, Aptar will hold a conference call on Friday, July 30, 2021 at 8:00 a.m. Central Time to discuss the Company's second quarter results for 2021. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investors page of the webs